Terns Pharmaceuticals TERN
Last Price
52 Week Range
$1.87 - $48.26
Next Earnings Date
Mar 19 2026 (Estimate)
Next Earnings Date
Mar 19 2026 (Est.)
Last Price
TERN Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Terns Pharmaceuticals, Inc. | 8-K | December 11, 2025 | |
Terns Pharmaceuticals, Inc. | S3ASR | December 9, 2025 | |
Terns Pharmaceuticals, Inc. | 8-K | December 8, 2025 | |
Terns Pharmaceuticals, Inc. | 10-Q | November 10, 2025 | |
Terns Pharmaceuticals, Inc. | 8-K | November 10, 2025 | |
Terns Pharmaceuticals, Inc. | 8-K | November 3, 2025 | |
Terns Pharmaceuticals, Inc. | 8-K | October 22, 2025 | |
Terns Pharmaceuticals, Inc. | 8-K | August 5, 2025 | |
Terns Pharmaceuticals, Inc. | 10-Q | August 5, 2025 | |
Terns Pharmaceuticals, Inc. | 8-K | June 16, 2025 | |
Terns Pharmaceuticals, Inc. | 8-K | May 8, 2025 | |
Terns Pharmaceuticals, Inc. | 10-Q | May 8, 2025 | |
Terns Pharmaceuticals, Inc. | ARS | April 29, 2025 | |
Terns Pharmaceuticals, Inc. | DEF 14A | April 29, 2025 | |
Terns Pharmaceuticals, Inc. | DEFA14A | April 29, 2025 | |
Terns Pharmaceuticals, Inc. | 8-K | March 20, 2025 | |
Terns Pharmaceuticals, Inc. | 10-K | March 20, 2025 | |
Terns Pharmaceuticals, Inc. | 8-K | February 24, 2025 | |
Terns Pharmaceuticals, Inc. | 8-K | February 20, 2025 | |
Terns Pharmaceuticals, Inc. | 8-K | February 6, 2025 | |
Terns Pharmaceuticals, Inc. | 8-K | December 3, 2024 | |
Terns Pharmaceuticals, Inc. | 8-K | November 18, 2024 | |
Terns Pharmaceuticals, Inc. | 8-K | November 12, 2024 | |
Terns Pharmaceuticals, Inc. | 10-Q | November 12, 2024 | |
Terns Pharmaceuticals, Inc. | 8-K | September 12, 2024 | |
Terns Pharmaceuticals, Inc. | 8-K | September 9, 2024 | |
Terns Pharmaceuticals, Inc. | 8-K | August 5, 2024 | |
Terns Pharmaceuticals, Inc. | 10-Q | August 5, 2024 | |
Terns Pharmaceuticals, Inc. | 8-K | July 29, 2024 | |
Terns Pharmaceuticals, Inc. | 8-K | July 3, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.